← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 31, 2016Last known activity
Dec 10, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 10 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Recent trials (17)
- NCT07294391Sponsor investigatorPhase 2Dec 10, 2025
- NCT07294391Lead sponsorPhase 2Dec 10, 2025
- NCT06939166Lead sponsorEarly Phase 1Jun 30, 2025
- NCT06939166Sponsor investigatorEarly Phase 1Jun 30, 2025
- NCT06172387Lead sponsorPhase 1Nov 1, 2023
- NCT06172387Reponsible party - principal investigatorPhase 1Nov 1, 2023
- NCT06113848Lead sponsorPhase 3Sep 7, 2023
- NCT06113848Reponsible party - principal investigatorPhase 3Sep 7, 2023
- NCT05965687CollaboratorPhase 3Aug 17, 2023
- NCT05965193CollaboratorPhase 3Aug 17, 2023
- NCT05953623Lead sponsorPhase 1Aug 1, 2023
- NCT05953623Reponsible party - principal investigatorPhase 1Aug 1, 2023
- NCT05404373CollaboratorN/AJun 20, 2022
- NCT04715620Lead sponsorPhase 2Jan 31, 2021
- NCT04715620Reponsible party - principal investigatorPhase 2Jan 31, 2021
Details
- Last known activity
- Dec 10, 2025